NIH-Sponsored Trial of Lassa Vaccine Opens - Viral Hemorrhagic Disease Can be Fatal & Causes Permanent Hearing Loss ...

NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

Six years before the start of the COVID-19 pandemic, an Ebola outbreak in West Africa had people fearing the possibility of a ...

The Ogun State government, yesterday, confirmed a case of Lassa fever, officially declaring an outbreak in the state.The Commissioner for Health, Dr Tomi Coker, in a statement, disclosed that the ...

By Adejoke AdeleyeOgun government has confirmed the outbreak of Lassa fever in the state with an index death case of a 25-year-old female corps member recorded.The state government in a statement ...

Laboratory testing has proven that a recent deadly disease outbreak in the Democratic Republic of Congo was caused by malaria ...

Lassa fever vaccine is one step closer to approval. Lassa virus infections, primarily spread by rodents, can cause a fatal ...

It claimed the life of a 25-year-old female NYSC member who fell sick in Ondo and was brought to a health facility at Ijebu North Local Government where she died.